Scenarios that move ZLAB
Zai Lab Limited - American Depositary Shares
Scenarios that move ZLAB: 4 analyses, 2 positive, 2 negative.
- · argenx meets primary endpoint in Phase II celiac disease study — ▼ · impact -18 · confidence low · horizon quarters
- · Novartis acquires Abogen in $7.8B RNA therapeutics deal — ▲ · impact +33 · confidence low · horizon immediate
- · Novo and Hengrui sign exclusive license for oral GLP-1/GIP drug — ▲ · impact +35 · confidence low · horizon immediate
- · CHMP backs CORT's Lifyorli combo for ovarian cancer — ▼ · impact -25 · confidence low · horizon quarters